Showing 1 - 20 results of 24 for search 'Huiqiang Huang', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
PB1733: LONG-TERM FOLLOW-UP FOR PATIENTS WITH T CELL LYMPHOBLASTIC LYMPHOMA/ ACUTE LYMPHOBLASTIC LEUKEMIA WHO RECEIVED MODIFIED BFM PROTOCOLS by Yan Gao, Liqin Ping, Xiaoxiao Wang, Bing Bai, Xuanye Zhang, Qingqing Cai, Zhi-Ming LI, Huang He, Liang Yang, Yizhuo Zhang, Huiqiang Huang
Published 2023-08-01
Article -
8
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA du... by Qingqing Cai, Kailin Chen, Jie Chen, Shaoxu Wu, Qirong Geng, Huiqiang Huang, Tongyu Lin, Wenqi Jiang, Zhongjun Xia, Huaxin Duan, Huilan Rao, Mengfei Yao, Liyang Hu
Published 2016-01-01
Article -
9
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma by Xiaoqing Chen, Yunwei Hu, Wenru Su, Shizhao Yang, Xiaoxiao Wang, Ping Zhang, Xiaoyu Hong, Chuqiao Liang, Zhuyun Qian, Ziqiang Li, Yong Tao, Huiqiang Huang, Dan Liang
Published 2022-11-01
Article -
10
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma by Jun Cai, Panpan Liu, Huiqiang Huang, Yajun Li, Shuyun Ma, Hui Zhou, Xiaopeng Tian, Yuchen Zhang, Yan Gao, Yi Xia, Xuanye Zhang, Hang Yang, Lirong Li, Qingqing Cai
Published 2020-12-01
Article -
11
PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL... by Yan Gao, Liling Zhang, Sujun Gao, Yu Yang, Qing-Yuan Zhang, Huilai Zhang, Pengcheng He, Fei LI, Hongmei Jing, Susan Grange, Lilian Bu, Qianming Wang, Yanjie Wang, Huiqiang Huang
Published 2023-08-01
Article -
12
P1136: FIRST INTERIM ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA by Huilai Zhang, Ying Cheng, Hai-Yan Yang, Liling Zhang, Liqun Zou, Ye Guo, Junning Cao, Huiqiang Huang, Zhao Wang, Sha Huang, Zhiyu Liang, Jiaoyan Lyu, Yiqian Fang, Aileen Cohen, Keshu Zhou
Published 2023-08-01
Article -
13
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study by Meng Wu, Yun Li, Yun Li, Huiqiang Huang, Wei Xu, Yanyan Wang, Haiwen Huang, Haiwen Huang, Weili Zhao, Shuo Liu, Shuo Liu, Pengpeng Xu, Zhengming Chen, Jun Zhu, Yuqin Song, Jia Ruan, Depei Wu, Depei Wu
Published 2022-01-01
Article -
14
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell ly... by Jun Zhu, Xiaonan Hong, Yu Qin Song, Brendan Hodkinson, Sriram Balasubramanian, Songbai Wang, Qingyuan Zhang, Yuankai Shi, Huiqiang Huang, Huilai Zhang, Yan Zhu, Stephen Martin Shreeve, Steven Sun, Ze Wang, Xiaocan Wang, Yue Fan, Wyndham Wilson, Jessica Vermeulen
Published 2022-11-01
Article -
15
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study by Yuchen Zhang, Panpan Liu, Jun Cai, Hongmei Jing, Liqun Zou, Huiqiang Huang, Yuanbin Wu, Wenyu Li, Liye Zhong, Xueli Jin, Xu Ye, Ru Feng, Huilai Zhang, Liling Zhang, Lie Lin, Xiuhua Sun, Yuyang Tian, Zhongjun Xia, Zhiming Li, He Huang, Yi Xia, Qingqing Cai
Published 2022-11-01
Article -
16
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma by Yali Wang, Wenbo Zhou, Jianfeng Chen, Jinghong Chen, Peng Deng, Huang Chen, Yichen Sun, Zhaoliang Yu, Diwen Pang, Lizhen Liu, Peili Wang, Jing Han Hong, Bin Tean Teh, Huiqiang Huang, Wenyu Li, Zhengfang Yi, Soon Thye Lim, Yihua Chen, Choon Kiat Ong, Mingyao Liu, Jing Tan
Published 2023-08-01
Article -
17
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies by Yuqin Song, Shang-Ju Wu, Zhixiang Shen, Donglu Zhao, Thomas Sau Yan Chan, Huiqiang Huang, Lugui Qiu, Jianyong Li, Tran-der Tan, Jun Zhu, Yongping Song, Wei-Han Huang, Weili Zhao, Herman Sung Yu Liu, Wei Xu, Naizhi Chen, Jun Ma, Cheng-Shyong Chang, Eric Wai Choi Tse
Published 2023-10-01
Article -
18
P1172: ARTIFICIAL INTELLIGENCE FOR PROGNOSIS PREDICTION OF NATURAL KILLER/T-CELL LYMPHOMA BASED ON MAGNETIC RESONANCE IMAGING by Qingqing Cai, Chaofeng LI, Liang Wang, Chuanmiao Xie, Yuchen Zhang, Yishu Deng, Qihua Zou, Bingzhong Jing, Peiqiang Cai, Xiaopeng Tian, Yi Cao, Yu Yang, Bingzong LI, Fang Liu, Zhihua LI, Zaiyi Liu, Shiting Feng, Tingsheng Peng, Yujun Dong, Xinyan Wang, Guangying Ruan, Yun He, Huiqiang Huang, Yang Liang
Published 2023-08-01
Article -
19
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study by Huiqiang Huang, Jun Zhu, Ming Yao, Tae Min Kim, Dok Hyun Yoon, Seok-Goo Cho, Hyeon Seok Eom, Soon Thye Lim, Su-peng Yeh, Yuqin Song, Yok Lam Kwong, Jin Seok Kim, Jie Jin, Yuankai Shi, HyeJin Kim, Min Qing, Tianyuan Zhou, Grace Gao, Zongqi Dong, Ming Qi, Won Seog Kim
Published 2021-02-01
Article -
20
The dual role of CD70 in B‐cell lymphomagenesis by Man Nie, Weicheng Ren, Xiaofei Ye, Mattias Berglund, Xianhuo Wang, Karin Fjordén, Likun Du, Yvonne Giannoula, Dexin Lei, Wenjia Su, Wei Li, Dongbing Liu, Johan Linderoth, Chengyi Jiang, Huijing Bao, Wenqi Jiang, Huiqiang Huang, Yong Hou, Shida Zhu, Gunilla Enblad, Mats Jerkeman, Kui Wu, Huilai Zhang, Rose‐Marie Amini, Zhi‐Ming Li, Qiang Pan‐Hammarström
Published 2022-12-01
Article